Milliner D - Search Results

1

End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.

Langman CB, Assimos D, Blank M, Calle J, Grauer A, Kausz A, Milliner D, Nazzal L, Smith K, Tasian G, Thompson A, Wood KD, Worcester E, Yang S, Malley MA, Knauf F, Lieske JC; Rare Kidney Stone Consortium (RKSC) Kidney Health Initiative (KHI) Oxalosis and Hyperoxaluria Foundation Enteric Hyperoxaluria Workgroup (OHF EH Workgroup). Langman CB, et al. Among authors: milliner d. Clin J Am Soc Nephrol. 2023 Dec 1;18(12):1637-1644. doi: 10.2215/CJN.0000000000000234. Epub 2023 Jun 21. Clin J Am Soc Nephrol. 2023. PMID: 37342976

2

Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.

Nebeker HG, Andress DL, Milliner DS, Ott SM, Alfrey AC, Slatopolsky EA, Sherrard DJ, Coburn JW. Nebeker HG, et al. Among authors: milliner ds. Kidney Int Suppl. 1986 Feb;18:S96-9. Kidney Int Suppl. 1986. PMID: 3458006 No abstract available.

3

Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions.

Milliner DS, Shinaberger JH, Shuman P, Coburn JW. Milliner DS, et al. N Engl J Med. 1985 Jan 17;312(3):165-7. doi: 10.1056/NEJM198501173120307. N Engl J Med. 1985. PMID: 3965935 No abstract available.

4

Interpretation of serum aluminum values in dialysis patients.

McCarthy JT, Milliner DS, Kurtz SB, Johnson WJ, Moyer TP. McCarthy JT, et al. Among authors: milliner ds. Am J Clin Pathol. 1986 Nov;86(5):629-36. doi: 10.1093/ajcp/86.5.629. Am J Clin Pathol. 1986. PMID: 3776914

5

Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome.

Norris KC, Crooks PW, Nebeker HG, Hercz G, Milliner DS, Gerszi K, Slatopolsky E, Andress DL, Sherrard DJ, Coburn JW. Norris KC, et al. Among authors: milliner ds. Am J Kidney Dis. 1985 Nov;6(5):342-7. doi: 10.1016/s0272-6386(85)80091-3. Am J Kidney Dis. 1985. PMID: 4061454 No abstract available.

6

Pulmonary calcinosis after renal transplantation in pediatric patients.

Milliner DS, Lieberman E, Landing BH. Milliner DS, et al. Am J Kidney Dis. 1986 Jun;7(6):495-501. doi: 10.1016/s0272-6386(86)80191-3. Am J Kidney Dis. 1986. PMID: 3521266

7

Changes in bone histology after treatment with desferrioxamine.

Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ. Ott SM, et al. Among authors: milliner ds. Kidney Int Suppl. 1986 Feb;18:S108-13. Kidney Int Suppl. 1986. PMID: 3457986 No abstract available.

8

Effect of a Novel Clinical Decision Support Tool on the Efficiency and Accuracy of Treatment Recommendations for Cholesterol Management.

Scheitel MR, Kessler ME, Shellum JL, Peters SG, Milliner DS, Liu H, Komandur Elayavilli R, Poterack KA, Miksch TA, Boysen J, Hankey RA, Chaudhry R. Scheitel MR, et al. Appl Clin Inform. 2017 Feb 8;8(1):124-136. doi: 10.4338/ACI-2016-07-RA-0114. Appl Clin Inform. 2017. PMID: 28174820 Free PMC article.

9

Clearance of aluminum by hemodialysis: effect of desferrioxamine.

Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW. Milliner DS, et al. Kidney Int Suppl. 1986 Feb;18:S100-3. Kidney Int Suppl. 1986. PMID: 3457984 Clinical Trial. No abstract available.

10

Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2.

Milliner DS, Wilson DM, Smith LH. Milliner DS, et al. J Nephrol. 1998 Mar-Apr;11 Suppl 1:56-9. J Nephrol. 1998. PMID: 9604813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page